Replimune Group, Inc.
REPLFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Replimune Group, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 10 annual periods. The latest annual period ends Mar 31, 2026. The latest insider filing shown is dated Jun 3, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Nuveen, LLC | 2026-03-31 | 57,614 | $441K | SEC filing |
| GF FUND MANAGEMENT CO. LTD. | 2026-03-31 | 1,752 | $13.4K | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 300,833 | $2.3M | SEC filing |
| Advisory Services Network, LLC | 2026-03-31 | 1,228 | $9.39K | SEC filing |
| Cerity Partners LLC | 2026-03-31 | 18,422 | $141K | SEC filing |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-03-31 | 52,407 | $401K | SEC filing |
| BAKER BROS. ADVISORS LP | 2026-03-31 | 11,045,336 | $84.5M | SEC filing |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2026-03-31 | 1,586 | $12.1K | SEC filing |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 2026-03-31 | 3,000 | $22.8K | SEC filing |
| Blueshift Asset Management, LLC | 2026-03-31 | 15,566 | $119K | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 381,453 | $2.92M | SEC filing |
| Smartleaf Asset Management LLC | 2026-03-31 | 79 | $569 | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 2,141 | $16.4K | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 204,791 | $1.57M | SEC filing |
| Rafferty Asset Management, LLC | 2026-03-31 | 118,476 | $906K | SEC filing |
| Tidal Investments LLC | 2026-03-31 | 106,885 | $818K | SEC filing |
| E Fund Management Co., Ltd. | 2026-03-31 | 14,893 | $114K | SEC filing |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2026-03-31 | 388 | $2.97K | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 89,622 | $686K | SEC filing |
| Root Financial Partners, LLC | 2026-03-31 | 32 | $245 | SEC filing |
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-01 | Sarchi Christopher · Chief Commercial Officer | Common Stock | S — Open market or private sale | −12,000 | 9.24 | SEC filing |
| 2026-05-18 | Schwendenman Andrew · Chief Accounting Officer | Common Stock | S — Open market or private sale | −7,894 | 5.08 | SEC filing |
| 2026-05-18 | Hill Emily Luisa · Chief Financial Officer | Common Stock | S — Open market or private sale | −7,812 | 5.08 | SEC filing |
| 2026-05-18 | Sarchi Christopher · Chief Commercial Officer | Common Stock | S — Open market or private sale | −8,626 | 5.08 | SEC filing |
| 2026-05-18 | Patel Sushil · Chief Executive Officer | Common Stock | S — Open market or private sale | −37,324 | 5.08 | SEC filing |
| 2026-05-18 | Xynos Konstantinos · Chief Medical Officer | Common Stock | S — Open market or private sale | −14,023 | 5.08 | SEC filing |
| 2026-05-18 | Astley-Sparke Philip · Director | Common Stock | S — Open market or private sale | −17,657 | 5.08 | SEC filing |
| 2026-04-02 | Sarchi Christopher · Chief Commercial Officer | Common Stock | S — Open market or private sale | −6,500 | 8.01 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-01 | Astley-Sparke Philip · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +75,000 | SEC filing |
| 2026-04-01 | BAKER JULIAN · Director, 10% owner | Non-Qualified Stock Option (right to buy)uy) | A — Grant, award, or other acquisition | +44,500 | SEC filing |
| 2026-04-01 | Peeples-Dyer Veleka · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +44,500 | SEC filing |
| 2026-04-01 | Xynos Konstantinos · Chief Medical Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +75,000 | SEC filing |
| 2026-04-01 | SLATTERY JOSEPH P · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +44,500 | SEC filing |
| 2026-04-01 | Sarchi Christopher · Chief Commercial Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +75,000 | SEC filing |
| 2026-04-01 | Dhingra Kapil · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +44,500 | SEC filing |
| 2026-04-01 | Schwendenman Andrew · Chief Accounting Officer | Common Stock | A — Grant, award, or other acquisition | −36,667 | SEC filing |
Showing 8 of 22 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.